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Abstract
Background: The heart was very sensitive to fluctuating thyroid hormone levels. To assess
intra-left ventricular (LV) systolic asynchrony in patients with subclinical thyroid dysfunction.
Methods: Fifty patients with subclinical hypothyroidism and 40 controls were included.
A diagnosis of subclinical hypothyroidism was reached with increased TSH and normal free T4.
All subjects were evaluated by echocardiography. Evaluation of intra-LV systolic asynchrony
was performed by tissue synchronization imaging (TSI), and four TSI parameters of systolic
asynchrony were calculated. LV asynchrony was defined by these parameters.
Results: All of the groups were similar in terms of demographic findings and conventional
and Doppler echocardiograpic parameters except peak systolic velocity and early diastolic
velocity. LV systolic asynchrony parameters of TSI including; standard deviation of Ts of the
12 LV segments (Ts-SD-12), maximal difference in Ts between any 2 of the 12 LV segments
(Ts-12), standard deviation of TS of the 6 basal LV segments (Ts-SD-6), maximal difference
in Ts between any of the 6 basal LV segments (Ts-6) were significantly lengthened in patients
with subclinical hypothyroidism than controls (p < 0.001, p < 0.001, p < 0.001 and p < 0.001,
respectively). The prevalence of LV asynchrony was significantly higher in patients with sub-
clinical hypothyroidism than control.
Conclusions: Patients with subclinical hypothyroidism present evidence of LV asynchrony by
TSI. LV systolic asynchrony could be a warning sign of the early stage in cardiac systolic
dysfunction in subclinical hypothyroid patients. (Cardiol J 2012; 19, 4: 374–380)
Key words: left ventricular asynchrony, thyroid stimulating hormone, tissue
synchronization imaging
Introduction
Thyroid hormone receptors are abundant in the
myocardium, so the heart is extremely sensitive to
the thyroid hormones [1]. There are many regula-
tory effects of thyroid hormones, such as cardiac
protein transcription, gene expression, [2] impaired
myocardial contractility, decreased cardiac output,
variability of heart rate, increased systemic vascu-
lar resistance, [3] cardiomyocyte atrophy, endothe-
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lial dysfunctions, [4, 5] higher prevalence of athero-
sclerosis and development of heart failure [6, 7].
Some clinical studies have shown that even in the
form of subclinical hyperthyroidism and subclinical
hypothyroidism were associated with changes in
various cardiac parameters [8–10]. Subclinical hy-
pothyroidism is associated with left ventricular (LV)
diastolic dysfunction qualified by slowed myocardial
relaxation and disabled rapid ventricular filling, both
at rest and with exercise. Frequently this is relat-
ed with a changeable impairment in LV systolic
function even at the very early stage [11, 12].
LV asynchrony is defined as deterioration of
the simultaneous contraction of corresponding car-
diac segments. Because of this, delayed activation
of some ventricular segments leads to uncoordinat-
ed contraction. LV asynchrony may affect the dias-
tolic and systolic function, exercise capacity, prog-
nosis, quality of life and symptoms of heart failure,
so, it may lead to deterioration of heart failure. Pre-
vious studies commonly used QRS duration for the
definition of LV asynchrony and decision of resyn-
chronization therapy [13]. But, the developments
in echocardiographic methods enabled the direct
assessment of mechanical asynchrony [14, 15].
Recently, it has been shown that overt hypothyro-
idism [16] and clinical hyperthyroidism [17] were
impaired LV synchronicity. However subclinical
thyroid dysfunction causes LV asynchrony has not
been evaluated. In this way, the aim of the present
study was to evaluate intra-LV systolic asynchro-
ny in patients with subclinical thyroid disorders.
Methods
Study population
We studied 50 patients (37 female and 13 male
with mean age of 38.6 ± 11.5 years) with subclini-
cal hypothyroidism who were newly or untreated,
previously diagnosed patients in endocrine clinic.
The study patients had normal sinus rhythm and
narrow QRS complex on electrocardiography
(ECG). In addition, 40 healthy control subjects
(30 female and 10 male with mean age of 39.0 ± 10.1
years) were included. The diagnosis of subclinical
hypothyroid was reached with increased serum
TSH (> 4.0 mU/L) and normal free T4 (fT4) levels
in fasting blood samples (normal values in our la-
boratory were; 0.4–4.0 mU/L for TSH and 0.9–1.9 ng/
/mL for fT4). All subjects’ triiodothyronine (fT3)
level was found normal. The entire study popula-
tion’s demographic characteristics, biochemical
parameters, lipid values and ECGs were obtained.
Exclusion criteria were as follows: overt hypothy-
roidism or hyperthyroidism, acute coronary syn-
drome, prior myocardial infarction and coronary
artery disease, congestive heart failure, LV hyper-
trophy, prolonged QRS duration (≥ 120 ms), re-
duced LV ejection fraction (LVEF < 55%), chronic
obstructive pulmonary disease, significant valvular
heart disease, pacemaker implantation, atrial flutter
or fibrillation, frequent ventricular pre-excitation
and atrio-ventricular conduction abnormalities, hyper-
tension (resting blood pressure ≥ 140/90 mm Hg),
diabetes mellitus, medications known to alter car-
diac conduction, peripheral vascular diseases, pul-
monary or neurological disease, pericarditis, con-
genital heart disease, alcohol abuse, renal or hepatic
disease and poor echocardiographic imaging. Ap-
proval for the study was obtained by the local eth-
ics committee. All subjects included in the study
singed upon inform consent with careful explana-
tion of the study procedures.
Standard echocardiography
All patients were evaluated by transthoracic
M- mode, two dimensional (2D), pulsed-wave (PW),
continuous wave (CW), color flow and tissue Dop-
pler imaging (TDI). All examinations were per-
formed with the GE-Vivid-7 system (GE Vingmed,
Horten, Norway) with a 2–4 MHz transducer at
a dept of 16 cm. During echocardiography, continu-
ous single-lead ECG recording was obtained. All
patients were imaged in the left lateral decubitus
position. 2D and conventional Doppler examinations
were obtained in the parasternal and apical views
according to the guidelines of the American Socie-
ty of Echocardiography [18]. LV diameters and wall
thickness was measured by M-mode echocardio-
graphy. LVEF was calculated using the apical 2- and
4-chamber views by Simpson’s method, according
to American Society of Echocardiography guide-
lines [18]. The mitral valve inflow pattern [E-wave,
A-wave, E-wave deceleration time (Dt), E/A ratio
and isovolumic relaxation time (IVRT)] were mea-
sured using pulsed wave Doppler. LV mass index
was calculated using the formula with the Deveraux
equation [19, 20].
Tissue Doppler echocardiography
TDI was performed by transducer frequencies
of 3.5 to 4.0 MHz, adjusting the spectral pulsed
Doppler signal filters to acquire the Nyquist limit
of 15 to 20 cm/s was reached and using the minimal
optimal gain. Myocardial TDI velocities (peak sys-
tolic [Sm], early diastolic [Em] and late diastolic
velocities [Am]) were measured via spectral pulsed
Doppler as of the LV-free wall from the apical
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4-chamber view [18]. TDI was performed using api-
cal 4-chamber, apical 2-chamber and apical long-axis
views for motion of the ventricle.
Evaluation of intra-LV systolic asynchrony was
performed by tissue synchronization images (TSI)
[21]. It was a parametric imaging tool derived by
2D TDI images. TSI exhibits regional asynchrony
on 2D echocardiography and enables the evaluation
of regional delay in systole. TSI is calculated auto-
matically and color-codes for the time to peak tis-
sue velocity (Ts) in each position in the image with
reference to the QRS signal [22, 23]. The algorithm
of TSI defines positive velocity peaks within a spec-
ified time period and the color coding ranges from
green (first), yellow, orange and red (latest) within
this period. Initially, the event timing tool was mea-
sured manually the time from the onset of the QRS
to the aortic valve opening and closure and sepa-
rately recorded pulsed Doppler spectrum. The
event timing tool allows the start and end times of
TSI. Then it adjusted manually to align with the
corresponding aortic valve opening and closure
markers on ECG. Therefore, peak systolic veloci-
ties outside the ejection phase will be measured.
In addition, for qualitative measurement of the wall
with most severe delay was identified on the basis
of TSI at the three apical views. A quantitative
measurement device allowed numerical calculation
of the median time to peak velocity within a 6-mm
sample volume manually positioned within the 2D
TSI image for 12 LV. At least three consecutive
beats were stored and the images were analyzed
offline for TSI by a customized software package
(EchoPac for PC, GE Vingmed Ultrasond) [21]. The
six-basal and six mid-segmental model was used
[21–23]. Four parameters of intra-LV asynchrony
were recorded only ejection phase included:
— standard deviation of Ts of the 12 LV segments
(Ts-SD-12);
— maximal difference in Ts between any 2 of the
12 LV segments (Ts-12);
— standard deviation of Ts of the 6 basal LV seg-
ments (Ts-SD-6);
— maximal difference in Ts between any of the
6 basal LV segments (Ts-6) [16].
Ts-SD-12 is the most widely used parameter
of intra-LV asynchrony [21–23]. Ts-SD-12 more
than 31.4 ms is defined that intra-LV systolic asyn-
chrony by TSI [19]. All measurements were per-
formed by two experienced investigators, who were
unaware of the subject’s clinical status. If a differ-
ence of > 5% in any of the variables measured by
both investigators was found, the patient was not
included, whereas if the difference was < 5%, the
measurements were averaged.
Statistical analysis
All analyses were performed using the SPSS
(SPSS for Windows 15.0) software package. Contin-
uous variables were presented as mean ± standard
deviation. Categorical variables were presented as
the percentage. Fisher exact test and continuity cor-
rection were used for categorical variables and un-
paired t-test was used for continuous variables if
appropriate. Pearson’s and Spearmen correlation
exponents were used to force of relationship be-
tween continuous variables. Linear multivariate re-
gression analysis was used to recognize the signifi-
cant determinants intra-LV asynchrony. A value of
p < 0.05 was considered statistically significant.
Results
Patients characteristics
The baseline demographic and biochemical
parameters of the groups are demonstrated in
Table 1. Both of groups had similar demographic
findings such as age, sex, body mass index (BMI),
smoking, heart rate, systolic and diastolic blood
pressure and lipid levels (p > 0.05). Unsurprising-
ly, patients with subclinical hypothyroidism had sig-
nificantly higher TSH and significantly lower fT4
(p < 0.001 and p < 0.001, respectively).
Echochardiographic parameters
and asynchrony
Both of groups were similar in terms of con-
ventional and Doppler echocardiograpic parameters
(Table 1). Peak systolic velocity (Sm) and early dia-
stolic velocity (Em) were significantly lower in
patients with subclinical hypothyroid patients on
TDI compared with controls (p = 0.027 and p = 0.021,
respectively). Additionally, Although, left atrial
diameter and late diastolic mitral annular velocity
(Am) were higher in patients with subclinical
hypothyroidism but these did not reach statistical
significance (Table 2). Intra-LV systolic asynchro-
ny parameters of TSI including Ts-SD-12, Ts-12,
Ts-SD-6 and Ts-6 were significantly lengthened in
patients with subclinical hypothyroid than controls
(p < 0.001, p < 0.001, p < 0.001 and p < 0.001).
The frequency of intra-LV systolic asynchrony de-
fined as Ts-SD-12-ejection more than 31.4 ms was
significantly higher in patients with subclinical hy-
pothyroid than controls (73.3% and 9.3%, p < 0.001,
respectively).
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Correlation between intra-LV asynchrony
and other parameters
Positive correlation was found between Ts-SD-
-12 and TSH in patients with subclinical hypothyroid-
ism (r = 0.24, p = 0.047, Fig. 1). There was negative
correlation between Ts-SD-12 and Em in patients with
subclinical hypothyroid. In addition Sm and Am was
not correlated with intra-LV asynchrony.
Linear multivariate regression analysis (included
age, gender, BMI, TSH, fT4, Em, Sm, Am, systolic
Table 1. Baseline demographic and biochemical characteristics of the groups.
Subclinic hypothyroid (n = 50) Control (n = 40) P
Age 38.6 ± 11.5 39.0 ± 10.1 0.726
Gender (female) 37 (74.0%) 30 (75.0%) 0.901
Smoking 10 (20.0%) 9 (22.5%) 0.586
BMI [kg/m2] 27.4 ± 4.6 28.3 ± 5.1 0.517
Heart rate [bpm] 74.6 ± 10.6 74.6 ± 9.0 0.869
SBP [mm Hg] 117.8 ± 18.3 119.1 ± 19.3 0.436
DBP [mm Hg] 77.8 ± 7.0 78.1 ± 8.3 0.572
Total cholesterol [mg/dL] 186.0 ± 26.7 186 ± 28.3 0.805
LDL [mg/dL] 114.7 ± 16.4 111.0 ± 18.3 0.588
HDL [mg/dL] 42.3 ± 7.1 42.5 ± 5.8 0.701
Triglyceride [mg/dL] 151 ± 28.2 152 ± 29.1 0.964
Glucose 95.6 ± 7.1 97.9 ± 14.2 0.547
Hemoglobin [g/dL] 13.4 ± 3.2 13.1 ± 2.8 0.692
Creatinine [mg/dL] 0.79 ± 0.18 0.77 ± 0.16 0.217
TSH 8.6 ± 4.9 2.0 ± 0.8 < 0.001
Free T3 2.9 ± 0.71 3.4 ± 0.83 0.492
Free T4 0.97 ± 0.12 1.25 ± 0.20 0.010
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; LDL — low density lipoprotein; HDL — high density lipo-
protein; TSH — thyroid stimulant hormone
Table 2. Standard and tissue Doppler echocardiographic charactheristics of subjects.
Subclinic hypothyroid (n = 50) Control (n = 40) P
LVESD [mm] 30.0 ± 3.5 30.1 ± 4.1 0.930
LVEDD [mm] 48.2 ± 5.5 47.2 ± 4.2 0.341
LVESV [mL] 27.7 ± 8.0 27.1 ± 5.3 0.868
LVEDV [mL] 82.7 ± 16.2 85.4 ± 18.0 0.177
IVS [mm] 10.1 ± 1.7 9.5 ± 1.5 0.216
PW [mm] 9.5 ± 1.2 9.2 ± 1.0 0.709
LA [mm] 35.0 ± 8.7 32.3 ± 6.1 0.180
E [cm/s] 77.8 ± 27.0 78.1 ± 18.3 0.572
A [cm/s] 66.0 ± 26.7 59.6 ± 22.3 0.305
DT [ms] 216.7 ± 36.4 211.0 ± 38.3 0.788
IVRT [ms] 90.3 ± 27.1 87.5 ± 25.8 0.701
LVMI 84.4 ± 18.2 83.2 ± 19.1 0.461
LVEF [%] 64.0 ± 18.2 64.4 ± 19.1 0.811
Sm [cm/s] 10.8 ± 2.2 12.3 ± 2.2 0.027
Em [cm/s] 11.4 ± 2.2 13.4 ± 1.9 0.021
Am [cm/s] 13.6 ± 3.1 12.8 ± 2.4 0.653
LVESD — left ventricular end systolic diameter; LVEDD — left ventricular end diastolic diameter; LVESV — left ventricular end systolic volume;
LVEDV — left ventricular end diastolic volume; IVS — interventricular septum; PW — posterior wall; LA — left atrium; E — early diastolic mitral
inflow velocity; A — late diastolic mitral inflow velocity; DT — deceleration time; IVRT — isovolumetric relaxation time; LVMI — left ventricular mass
index; LVEF — left ventricular ejection fraction; Sm — peak systolic mitral annular velocity; EM — early diastolic mitral annular velocity; Am — late
diastolic mitral annular velocity
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and diastolic blood pressure) demonstrated that,
TSH was the only independent factor of intra-LV
systolic asynchrony in patients with subclinical hy-
pothyroid (R2 = 0.459, b = 0.411; p = 0.017).
Discussion
The objective of this study was to analyze the
changes of intra-LV asynchrony in patients with
subclinical hypothyroidism by TSI. Asynchrony
parameters obtained by TSI (including Ts-SD-12,
Ts-12, Ts-SD-6 and Ts-6) significantly prolonged
in patients with subclinical hypothyroidism com-
pared with the control group. Additionally TSH was
the only independent factor of intra-LV asynchro-
ny in patients with subclinical hypothyroidism. Also,
Sm and Em velocities of mitral lateral-basal seg-
ment of LV were lower in patients with subclinical
hypothyroidism than control as concordant with
previous studies [24, 25].
The myocardium is well-known among tissues
that include thyroid hormone receptors [10]. Thy-
roid hormone deficiency can alter cardiac muscle
function by decreasing the activity of several en-
zymes involved in the regulation of myocyte cal-
cium fluxes [10] and the expression of several con-
tractile proteins [26]. In addition, thyroid hormone
has been shown to affect calcium uptake by the sar-
coplasmic reticulum, to stimulate plasma membrane
Ca-ATPase activity and to increase voltage-depen-
dent channels in animal ventricular cells [10, 26, 27].
The subclinical hypothyroidism is defined as an
asymptomatic state characterized by normal serum
concentration of fT4 and increased serum concen-
trations of TSH. Thus, it may seem surprising to find
cardiac alterations similar to those observed in overt
thyroid disorders. However, minute decrements in
hormone synthesis may over time leading to bio-
chemical and functional signs that are qualitatively
similar to those of thyroid disorders [28].
The relationship between thyroid gland and the
heart has been known for a long time. Accordingly,
the alterations in thyroid status may affect both the
LV diastolic and systolic function. Di Bello et al. [29]
investigated and reported that early systolic hyper-
deformability and hypercontractility together with
impaired diastolic function by strain echocardio-
graphy in patients with subclinical hyperthyroidism.
They speculated that the direct effect of thyroid
hormones on the heart may cause of these results.
Our results suggested that intra-LV systolic asyn-
chrony in subclinical hypothyroid patients. Also, in
our study we do not know disease duration and our
patients were younger age group. Therefore, thy-
roid hormones may have a direct action on ventric-
ular synchronization.
On the other way, thyroid hormones are also
effect transcriptions of structural and regulatory
proteins on the cardiovascular system [2]. Also,
mildly changes in blood levels of thyroid hormones
have many adverse effects on both function and
Figure 1. The correlation of standard deviation of time
to peak tissue velocity of the 12 left ventricular seg-
ments (Ts-SD-12) and thyroid stimulant hormone (TSH)
in patients with subclinical hypothyroidism.
Table 3. Comparison of parameters of tissue
synchronization imaging between the groups.
Subclinic Control P
hypothyroid (n = 40)
(n = 50)
Ts-SD-12 38.8 ± 14.9 23.8 ± 12.4 < 0.001
Ts-12 119.0 ± 33.2 70.2 ± 32.2 < 0.001
Ts-SD-6 33.6 ± 14.0 20.1 ± 15.3 < 0.001
Ts-6 102.7 ± 25.4 55.4 ± 18.0 < 0.001
Ts — time to peak tissue velocity; Ts-SD-12 — standard deviation
of Ts of the 12 LV segments; Ts-12 — maximal difference in Ts
between any 2 of the 12 LV segments; Ts-6 — maximal difference
in Ts between any 2 of the 6 basal LV segments; Ts-SD-6 — standard
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structure of the heart. These effects are decreased
cardiac contractility and cardiac output, cardiomyo-
cyte atrophy, [1–4] myocardial fibrosis and develo-
pment of heart failure [30, 31]. The most consis-
tent cardiac abnormality defined in subclinical hy-
pothyroid patients is LV diastolic dysfunction [11].
Aghini-Lombardi et al. [32] demonstrated that ear-
ly functional and textural alterations in subclinical
hypothyroid patients using intra-myocardial ultra-
sonic video-densitometry analysis. Similarly, in our
study suggests that intra-LV asynchrony in patients
with subclinical thyroid disorders. Impaired diasto-
lic function is a common finding in many cardiac di-
seases, and it often precedes and results in systolic
dysfunction. Additionally, myocardial fibrosis and
cardiomyocyte atrophy may cause LV systolic asyn-
chrony in patients with subclinical hypothyroid.
LV asynchrony may be assessing by different
echocardiographic techniques such as M-Mode,
TDI, TSI, and strain imaging. Previous studies sug-
gested that measuring Ts from myocardial velocity
curves of TDI was very useful for quantitative as-
sessment of systolic asynchrony [19, 22, 23]. There-
fore, Yu et al. [21] reported that TSI was a good
technique for assessing synchronization, so we used
TSI method in this study.
Limitations of the study
The major limitation the size of our study po-
pulation was relatively small. Secondly strain or
strain rate was not performed for LV asynchrony.
Nevertheless, strain and strain rate analysis are not
applicable for routine clinical use and difficult to
interpret strain images. In this study used TSI
method which is reliable, practical and less time
consuming.
Conclusions
The current study demonstrated that impaired
ventricular systolic synchronization in patients with
subclinical hypothyroidism by TSI. LV systolic
asynchrony could be a warning sign of the early
period in cardiac systolic dysfunction and heart fail-
ure in patients with subclinical hypothyroidism. In
addition, TSI is a useful method to determined in-
tra-LV asynchrony.
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